Cheryl Zimberlin

Cheryl Zimberlin, Ph.D., is part of M Ventures, the corporate Venture Capital arm of Merck KgAA. M Ventures takes an active role in company creation and investment, with the mandate to invest in innovative technologies and products with the potential to significantly impact Merck‘s core businesses. Prior to joining the team, she had a successful academic career at top-tier Universities, with a good track record publishing in top-tier academic journals, including Nature. She holds a Ph.D. in Oncology and MSc in Biotechnology. Currently, she holds board positions in several M Ventures portfolio companies.